NDA[removed]NDA[removed]Page 6 Baraclude™

First Page		Document Content
Date: 2009-03-31 15:18:19 Medicine Entecavir Lamivudine Hepatitis B Reverse-transcriptase inhibitor Viral hepatitis Nucleoside analogue Adefovir Antiretroviral drug Purines Chemistry Organic chemistry		NDA[removed]NDA[removed]Page 6 Baraclude™ Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 628,06 KB Share Document on Facebook

	DEPARTMENT OF BIOCHEMISTRY FRONTIERS PROFESSOR KENNETH JOHNSON Roger J. Williams Centennial Professor of Biochemistry, University of Texas, USA DATE DocID: 1pw8Q - View Document
	Abstract Conjugation of anticancer drugs to biocompatible water soluble polymers is an attractive approach to improve the drug’s blood solubility and stability, tumour targeting properties and antitumour efficiency, w DocID: 195HC - View Document
	2005 Bowden, S, R. McCaw, P. A. White, J. N. Crofts and C. K. Aitken[removed]Detection of multiple hepatitis C virus genotypes in a cohort of injecting drug users. Journal of Viral Hepatitis. 12:[removed]Bull, R. A., G. DocID: 11pEd - View Document
	Chapter 10 Final Discussion, Future Perspective and Conclusion 10.1 Final discussion To investigate the outcome of applying the polymer drug conjugation strategy to DocID: Zmnp - View Document
	Microsoft Word[removed]Peripheral Neuropathy amend bp.doc DocID: U7ZD - View Document